Australia’s active vaccine safety system


Deng L, Glover C, Dymock M, Pillsbury A, Marsh JA, Quinn HE, Leeb A, Cashman P, Snelling TL, Wood N, Macartney K. The short term safety of COVID‐19 vaccines in Australia: AusVaxSafety active surveillance, February – August 2021. Medical Journal of Australia. doi: 10.5694/mja2.51619. [Full text]

Phillips A, Glover C, Leeb A, Cashman P, Fathima P, Crawford C, Snelling TL, Durrheim D, Macartney K. Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance. BMJ Open. 2021;11:e043880 . [Abstract]

Totterdell J, Phillips A, Glover C, Chidwick K, Marsh J, Snelling T, Macartney K. Safety of live attenuated herpes zoster vaccine in adults 70 to 79 years: a self-controlled case series analysis using primary care data from the MedicineInsight program. Vaccine. 2020;38:3968-3979. [Abstract]

Glover C, Crawford N, Leeb A, Wood N, Macartney K. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety. Vaccine. 2020;38:4892-4900. [Abstract]

Pillsbury AJ, Fathima P, Quinn HE, Cashman P, Blyth CC, Leeb A, Macartney K . Comparative post-market safety profile of adjuvanted and high-dose influenza vaccines in the elderly. JAMA Open. 2020;3(5):e204079 . [Full text]

Jacoby P, Glover C, Damon C, Fathima P, Pillsbury A, Durrheim D, Gold M, Leeb A, Snelling T. Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study. BMJ Open 2020;10:e031851 . [Full text]

P. Cashman, S. Moberley, K. Chee, J. Stephenson, S. Chaverot, J. Martinelli, T. Gadsden, C. Bateman-Steel, L. Redwood, Z. Howard, M.J. Ferson and D.N. Durrheim. Participant centred safety surveillance of health care workers receiving influenza vaccination. Vaccine 2019;37:2427-2429. [Abstract]

Crawford NW, Hodgson K, Gold M, Buttery J, Wood N. Adverse evens following HPV immunisation in Australia: establishment of a clinical network. Human Vaccines and Immunotherapeutics 2016;12:2662-5. [Full text]

Cashman P, Macartney K, Khandaker G, King C, Gold M, Durrheim DN. Participant-centered active surveillance of adverse events following immunisation: a narrative review. International Health 2017;9:164-76. [Abstract]

Pillsbury A, Glover C, Jacoby P, Quinn HE, Fathima P, Cashman P, Leeb A, Blyth CC, Gold MS, Snelling T, Macartney K. Active surveillance of 2017 seasonal influenza vaccine safety in individuals aged 6 months and older in Australia. BMJ Open. 2018;8. [Full text]